CDLX

Cardlytics Inc
NASDAQCOMMUNICATION SERVICESADVERTISING AGENCIES

Key Statistics

Market Cap
$11.95M
P/E Ratio
—
EPS
$-18.99
Beta
0.71
52W High
$21.70
52W Low
$1.83
50-Day MA
$3.49
200-Day MA
$6.75
Dividend Yield
—
Profit Margin
-52.80%
Forward P/E
36.50
PEG Ratio
—

About Cardlytics Inc

Cardlytics, Inc. operates an advertising platform within financial institutions' digital channels including online, mobile, email, and various real-time notifications in the United States and the United Kingdom. The company is headquartered in Atlanta, Georgia.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$190.00M
Gross Profit (TTM)$92.86M
EBITDA$-13.97M
Operating Margin-14.70%
Return on Equity-513.00%
Return on Assets-7.37%
Revenue/Share (TTM)$34.49
Book Value$-2.76
Price-to-Book2.15
Price-to-Sales (TTM)0.06
EV/Revenue0.96
EV/EBITDA-7.69
Quarterly Earnings Growth (YoY)-56.70%
Quarterly Revenue Growth (YoY)-36.50%
Shares Outstanding$5.89M
Float$5.17M
% Insiders5.26%
% Institutions30.07%

Historical Volatility

HV 10-Day
130.54%
HV 20-Day
96.13%
HV 30-Day
93.46%
HV 60-Day
84.25%
HV Rank
—

Volatility is currently expanding

Latest News

Cardlytics and Rove Team Up to Help Travelers Earn Their Next Trip Faster

ATLANTA--(BUSINESS WIRE)--Cardlytics Inc. (NASDAQ: CDLX) today announced a new partnership with Rove, the first universal airline mile program built for Gen Z and Millennials, extending the Cardlytics Rewards Platform (CRP) and further diversifying Cardlytics' supply footprint.Since launching in 2025, Rove has quickly grown an active base of digitally native travelers and built out a roster of airline partners, making it one of the fastest growing rewards programs built specifically for the way.

Business Wire10/6/2026Neutral
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) announced that on Aug. 3, 2026, Cardlytics granted an aggregate of 50,000 restricted stock units of Cardlytics to its newly appointed Chief Legal Officer, Chris Cheng. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”). The restricted stock units shall v.

Business Wire8/3/2026Neutral
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that on July 29, 2026, the Compensation Committee of Cardlytics' Board of Directors granted an aggregate of 10,320 restricted stock units of Cardlytics to 10 newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”). For a.

Business Wire7/31/2026Neutral
Cardlytics Appoints Chris Cheng as Chief Legal Officer

ATLANTA--(BUSINESS WIRE)--Cardlytics Inc. (NASDAQ: CDLX) today announced the appointment of Chris Cheng as Chief Legal Officer, effective August 3, 2026. Cheng will serve on the Leadership Team and oversee Cardlytics Legal and Compliance organization. Cheng brings more than 20 years of legal leadership experience at high-growth technology companies, with deep expertise supporting public companies and partnering with executive teams during periods of transformation. With senior legal experience.

Business Wire7/29/2026Neutral
Cardlytics to Report Second Quarter 2026 Results on August 5

ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that its financial results for the second quarter ending June 30, 2026 will be released on August 5, 2026, after market close. Conference Call Details: When: August 5, 2026 at 5:00 pm Eastern time / 2:00 pm Pacific time Webcast: Attendees may access the live audio webcast on the Cardlytics Investor Relations website at ir.cardlytics.com, or by registering at this link. Following the call, a replay will be available on the.

Business Wire7/21/2026Neutral
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that on April 29, 2026, the Compensation Committee of Cardlytics' Board of Directors granted an aggregate of 272,000 restricted stock units of Cardlytics to six newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”). Fo.

Business Wire5/1/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CDLX and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More COMMUNICATION SERVICES Stocks

Data last updated: 10/17/2026